Table 3. Clinical randomized controlled trials of long-term oxytocin administration registered with the University Hospital Medical Information Network Clinical Trial Registry, Clinicaltrials.gov, and the Australian New Zealand Clinical Trials Registry.
Starting
Date |
Registered Database | Institute | Country | Duration | Dosage | Gender | Age | N | ||
---|---|---|---|---|---|---|---|---|---|---|
Amount | Frequency | |||||||||
2006.06. | NCT00490802 | [53] | Mount Sinai School of Medicine |
USA | 6 weeks | 24 IU | Twice per day | Both | 18-60 y.o. | 19 |
2009.06. | ACTRN12609000513213 | [55] | University of Sydney | Australia | 8 weeks | 18 or 24 IU | Twice per day | Male | 12-18 y.o. | 50 |
2009.09. | ACTRN12609000784213 | [54] | The University of New South Wales |
Australia | 4 days | 12 or 24 IU | Once per day | Male | 8-16 y.o. | 60 |
2009.10. | NCT01337687 | Albert Einstein College of Medicine |
USA | 8 weeks | 24 IU | Twice per day | Both | 18-55 y.o. | ||
2010.12. | ACTRN12611000061932 | [57] | University of Sydney | Australia | 5 weeks | Upward titration |
Twice per day | Both | 3-8 y.o. | 40 |
2011.03. | NCT01308749 | University of North Carolina |
USA | 8 weeks | 24 or 32 IU | Twice per day | Both | 3-17 y.o. | 25 | |
2011.03. | UMIN000005211 | University of Fukui | Japan | 12 weeks | 8 or 16 IU | Twice per day | Both | 15- y.o. | 60 | |
2011.09. | NCT01417026 | Children's Hospital of Philadelphia | USA | 5 days | 24 IU | Once per day | Male | 12-17 y.o. | 68 | |
2012.03. | UMIN000007122 | [56] | The University of Tokyo | Japan | 6 weeks | 24 IU | Twice per day | Male | 18-55 y.o. | 20 |
2012.03. | UMIN000007250 | Kanazawa University | Japan | 8 weeks | 8 IU | Twice per day | Male | 15-39 y.o. | 30 | |
2012.06. | NCT01624194 | Stanford University | USA | 4 weeks | 24 IU | Twice per day | Both | 6-12 y.o. | 50 | |
2012.11. | UMIN000009075 | Osaka University | Japan | 4 weeks | 24 IU | Twice per day | Male | 6-9 y.o. | 40 | |
2013.09. | NCT01908205 | Holland Bloorview Kids Rehabilitation Hospital/ University of Minnesota |
Canada/ USA |
24 weeks | 0.4 IU/kg (max 24IU) |
Twice per day | Both | 10-17 y.o. | 60 | |
2013.11. | NCT02007447 | University of Sao Paulo General Hospital | Brazil | 8 weeks | 24 IU | Twice per day | Male | 12-18 y.o. | 30 | |
2014.03. | NCT02090829 | University of Minnesota Department of Psychiatry | USA | 5 days | 24 IU | Once per day | Male | 12-17 y.o. | 52 | |
2014.04. | NCT01914939 | Massachusetts General Hospital | USA | 12 weeks | 24 IU | Once per day | Male | 18-30 y.o. | 150 | |
2014.06. | NCT01788072 | Holland Bloorview Kids Rehabilitation Hospital/ McMaster University |
Canada | 12 weeks | 24 IU | Twice per day | Both | 18-45 y.o. | 146 | |
2014.08. | NCT01944046 | University of North Carolina |
USA | 18 months | Upward titration |
Twice per day | Both | 3-17 y.o. | 300 | |
2014.10. | UMIN000015264 | The University of Tokyo/ Kanazawa University/ University of Fukui/ Nagoya |
Japan | 6 weeks | 24 IU | Twice per day | Male | 18-55 y.o. | 114 | |
2015.06. | UMIN000017876 | Osaka University | Japan | 4 weeks | 24 IU | Twice per day | Male | 6-10 y.o. | 10 |
Duration, duration of clinical trial; amount, dosage amount per single administration; frequency, dosage frequency per day; N, number of participants. y.o.: years old.